Pregnancy after Breast Cancer: From Psychosocial Issues Through Conception

ONCOLOGY

Volumn 12, Issue 5, 1998, Pages 759-769

  Collichio, Frances A ^a   Agnello, Richard ^b   Staltzer, Joan ^a  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b KING'S COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ESTRADIOL; FLUOROURACIL; FOLLITROPIN; LUTEINIZING HORMONE; MERCAPTOPURINE; METHOTREXATE; PRASTERONE; PREDNISONE; PROCARBAZINE; PROGESTERONE; PROLACTIN; TAMOXIFEN; TAMOXIFEN CITRATE; VINBLASTINE; VINCRISTINE SULFATE;

AGE; BIRTH DEFECT; BREAST CANCER; BREAST FEEDING; CANCER RECURRENCE; CLINICAL TRIAL; FEMALE INFERTILITY; HUMAN; MILK PRODUCTION; PREGNANCY; REVIEW; SEXUAL FUNCTION; SOCIAL PSYCHOLOGY;

ABNORMALITIES; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST FEEDING; BREAST NEOPLASMS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RECURRENCE; RISK FACTORS;

EID: 0031745380     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Petrek JA: Breast cancer during pregnancy Cancer 74:518-527, 1994.
2. Schover LR: The impact of breast cancer on sexuality, body image, and intimate relationships. CA: Cancer J Clin 41:112-120, 1991.
3. Schain W, Edwards BK, Gorrell CR, et al: Psychosocial and physical outcomes of primary breast cancer therapy Mastectomy vs excisional biopsy and irradiation. Breast Cancer Res Treat 3:377-382, 1983.
4. Fallowfield LJ, Baum M, Maquire GP: Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J Clinic Res Ed 293:1331-1334, 1986.
5. Kemeny MM, Wellisch DK, Schain WS: Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer. Cancer 62-1231-1237, 1988.
6. Schain WS, Wellisch DK, Pasnau RO, et al: The sooner the better: A study of psychological factors in women undergoing immediate versus delayed breast reconstruction. Am J Psychiatry 142:40-46, 1985
7. Noone RB, Frazier TG, Hayward CZ, et al: Patient acceptance of immediate reconstruction following mastectomy. Plast Reconstr Surg 69.632-640, 1982.
8. Stevens LA, McGrath MH, Druss RG, et al: The psychological impact of immediate breast reconstruction for women with early breast cancer. Plast Reconstr Surg 73:619-628, 1984.
9. Dean C, Chetty U, Forrest AP: Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet 1:459-462, 1983.
10. Andersen BL: How cancer affects sexual functioning. Oncology 4:81-88, 1990.
11. 10a. Ganz PA, Rowland JH, Desmond K, et al: Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16:501-514, 1998.
12. Reichman BS, Green KB: Breast cancer in young women: Effect of chemotherapy on ovarian function, fertility and birth defects. J Natl Cancer Inst 16:125-129, 1994.
13. Rose DP, Davis TE: Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet 1:1174-1176, 1977.
14. Dnistrian AM, Schwartz MK, Fracchia AA, et al: Endocrine consequences of CMF therapy in premenopausal and postmenopausal breast cancer patients. Cancer 51:803-807, 1983.
15. Samaan NA, DeAsis DN, Buzdar AU, et al: Pituitary-ovarian function in breast cancer patients on adjuvant chemotherapy. Cancer 41:2084-2087, 1978.
16. Koyama H, Wada T, Nishizawa Y, et al: Cyclophosphamide-induced ovanan failure and its therapeutic significance in patients with breast cancer. Cancer 39:1403-1409, 1977.
17. Goldhirsch A, Wood WC, Senn HJ, et al: Meetings highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 87:1441-1445, 1995.
18. Collichio F, Pandya K: Amenorrhea following chemotherapy for breast cancer: Effect on disease free survival. Oncology 8:45-52, 1994.
19. Bines J, Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729, 1996.
20. Hortobagyi GN, Buzdar AU, Marcus CE, et al: Immediate and long term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M. D. Anderson Hospital and Tumor Institute. NCI Monogr 1:105-109, 1986
21. Fisher B, Sherman B, Rockette H, et al: L-phentolamine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer Lack of association of disease-free survival with depression of ovarian function; National Surgical Adjuvant Project for Breast and Bowel Cancers. Cancer 44:847-857, 1979.
22. Sutton R, Buzdar AU, Hortobagyi GN: Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 39:1403-1409, 1977
23. Sobrinho LG, Lcvine RA, DeConti RC: Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents. Am J Obstet Gynecol 109-135-139, 1971.
24. Waxman J: Chemotherapy and the adult gonad: A review. J R Soc Med 76:144-148, 1983.
25. Santoro A, Bonadonna G, Valagussa P, et al. Long term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5:27-37, 1987.
26. Damewood MD, Grochow LB: Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 45:443-449, 1986.
27. Bianco AR, Del Mastro L, Gallo C, et al: Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. Br J Cancer 63:799-803, 1991.
28. Zemlickis D, Lishner M, Degendorfer, et al: Fetal outcomes after in utero exposure to cancer chemotherapy. Arch Intern Med 152:573-576, 1992.
29. Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 16:75-112, 1994.
30. Aviles A, Diaz-Maqueo JC, Talavera A, et al: Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children. Am J Hematol 36:243-248, 1991.
31. Bruner JA: Current Clinical Practice. Adjuvant chemotherapy for breast cancer in pregnancy: Can recommendations be made with confidence? Semin Oncol 24:35-36, 1997.
32. Ribeiro G, Jones DA, Jones M: Carcinoma of the breast associated with pregnancy. Br J Surg 73:607-609, 1986.
33. Malamos NA, Stathopoulos GP, Keramopoulos A et al: Pregnancy and offspring after the appearance of breast cancer. Oncology 53:471-475, 1996.
34. Dow KH, Harris JR, Roy C: Pregnancy after breast conserving surgery and radiation therapy for breast cancer. Natl Cancer Inst Monogr 16:131-137, 1994.
35. Dodds L, Marrett LD, Tomkins DJ, et al: Case-controlled study of congenital anomalies in children of cancer patients. Br Med J 30:164-168, 1993.
36. Hawkins MM: Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 83:1643-1650, 1991.
37. Mulvihill, JT, McKeen EA, Rosner F, et al: Pregnancy outcome in cancer patients: Experience in large cooperative groups. Cancer 60:1143-1150, 1987
38. Retic A, Sabesin S, Hume R, et al: Experimental transmission of malignant melanoma cells through the placenta. Surg Gyncol Obstet 114:485-489, 1962.
39. Pang C: Transplacental metastasis of Brown-Pearce rabbit tumors. Bull Tulane Med Fac 17:31, 1957
40. Dildy GA, Moise KJ, Carpenter RJ, et al: Maternal malignancy metastatic to the products of conception: A review Obstet Gynecol Surv 44:535-40, 1970.
41. Potter JF, Schoeneman M: Metastases of maternal cancer to the placenta and fetus. Cancer 25:380-388, 1970
42. Green JP: Post-irradiation lactation. Int J Radiat Oncol Biol Phys 17:244, 1989.
43. David FC: Lactation following primary radiation therapy for carcinoma of the breast. Int J Radiat Oncol Biol Phys 11:1425, 1985.
44. Findlay PA, Gorrell CR, D'Angelo T, et al: Lactation after breast irradiation. Int J Radiat Oncol Biol Phys 15:511-514, 1988
45. Wobbes TH: Effect of breast saving procedure on lactation. Eur J Surg 162:419-420, 1996.
46. Byers T, Graham S, Rzepka T, et al: Lactation and breast cancer: Evidence for negative association in premenopausal woman. Am J Epidemiol 121:664-674, 1985.
47. Michels KB, Willett WC, Rosner BA, et al: Prospective assessment of breastfeeding and breast cancer incidence among 89,887 women Lancet 347:431-36, 1996
48. McTiernan A, Thomas DB. Evidence for a protective effect of lactation on risk of breast cancer in young women: Result from a case control study. Am J Epidemiol 124:353-358, 1986.
49. Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330:81-87, 1994.
50. Dewailly E, Ayotte P, Brisson J: Protective effect of breast feeding on breast cancer and body burden of carcinogenic organochlorines. J Natl Cancer Inst 86:803, 1994.
51. American Society of Clinical Oncology: Recommended breast cancer surveillance guidelines. J Clin Oncol 15:2149-2156, 1997.
52. Ishida T, Yokoe T, Kasumi F et al: Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation Analysis of case control study in Japan. Jpn J Cancer Res 83:1143-1149, 1992.
53. Wallack MK, Wolf JA, Bedwinek J, et al: Gestational carcinoma of the female breast. Curr Prob Cancer 7:1-58, 1983.
54. Duncan KR: The development of magnetic resonance imaging in obstetrics. Br J Hosp Med 55:178-181, 1996.
55. Henderson BE, Bernstein L: Etiology and pathogenesis of breast cancer: Endogenous and exogenous hormonal factors, in Harris JR, Lippman MZ, Marrow M, et al (eds). Diseases of the Breast, pp 185-200. New York, Lippincott-Raven, 1996.
56. Kroman N, Jensen MB, Melbyem, et al: Should women be advised against pregnancy after breast cancer treatment? Lancet 350.319-322, 1997.
57. Danforth D: How subsequent pregnancy affects outcome in women with a prior cancer. Oncology 5:23-30, 1991.
58. Clark RM, Ried J. Carcinoma of the breast in pregnancy and lactation. Int J Radiat Oncol Biol Phys 4:693-698, 1978.
59. Schoultz E, Johansson H, Wilking N, et al: Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 13:430-434, 1995.
60. Cooper DR, Butterfield J: Pregnancy subsequent to mastectomy for cancer of the breast. Ann Surg 171:429-433, 1969.
61. Sankilar, Heinavaara S, Hakulinen T: Survival of breast cancer patients after subsequent term pregnancy: "Healthy mother effect." Am J Obstet Gynecol 170:818-823, 1994
62. Lethaby AE, O'Neill MA, Mason BH et al: Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer 67.75-755, 1996.
63. Mignot L, Morvan F, Sarrazin D, et al: Breast cancer and subsequent pregnancy (abstract). Proc Am Soc Clin Oncol 5:57, 1986.
64. Ariel IM, Kempner R: The prognosis of patients who become pregnant after mastectomy for breast cancer. Int Surg 74:185-187, 1989.
65. Petrek JA, Dukoff R, Rogatko A: Prognosis of pregnancy-associated breast cancer. Cancer 67:869-872, 1991.
66. Ingle JN, Ahmann DL, Green SJ et al: Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med 304:16-21, 1981.
67. Formby B: Immunologic response in pregnancy: Its role in endocrine disorder of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 24:187-205, 1995.
68. Gleicher N, Siegel I. Common denominators of pregnancy and malignancy. Prog Clin Biol Res 70.339-353,1981.
69. Patterson J, Furr B, Wakeeling A, et al. The biology and physiology of Nolvadex (tamoxifen) in the treatment of breast cancer. Breast Cancer Res Treat 2:363-374, 1982.
70. Powles TJ, Hickish T, Kanis JA, et al: Effect of tamoxifen on bone mineral density measured by x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14:78-84, 1996.
71. Love RR, Newcomb PA, Wiebe DA et al: Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst 82:1327-1332, 1990.
72. Cohen CJ: Tamoxifen and endometrial cancer. Tamoxifen effects on the female genital tract. Semin Oncol 24(1):S1-55-S1-64, 1997.
73. Fisher B, Constantino JP, Pedmont CK et al: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from NSABP B-14. J Natl Cancer Inst 86:527-537, 1994.
74. Jaiysimi IA, Buzdar AU, Decker DA et al: Use of tamoxifen for breast cancer: Twenty-eight years later. J Clin Oncol 13:513-529, 1995.
75. Jordan CV, Fritz NF, Langan-Fahey S, et al: Alteration of endocrine parameters, in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as a single agent J Natl Cancer Inst 83:1488-1491, 1991
76. Manni A, Pearson, OH: Antiestrogen-induced remissions in premenopausal woman with stage IV breast cancer: Effects on ovarian function. Cancer Treat Reports 64:779-785, 1980.
77. Chibbar R, Wong S, Miller FD, et al: Estrogen stimulates oxytocin gene expression in human chono-decidua. J Clin Endocrinol Metab 80:567-572, 1995.
78. Sharma SC, Purohit P, Rao AJ: Role of oestradiol-17 beta in the regulation of synthesis and secretion of human chorionic gonadotrophin by first trimester human placenta. J Mol Endocrinol 11:91-101, 1993.
79. Urabe M, Chetrite G, Pasqualini JR. Transformation of estrone, estradiol, and estrone sulfate in uterine and vaginal isolated cells of fetal guinea pig. Effect of various antiestrogens in the conversion of estrone sulfate to estradiol. Steroids 58:209-14, 1993.
80. Wisel MS, Datta JK, Saxena RN: Effects of anti-estrogens on early pregnancy in guinea pigs. Int J Fertil Menopausal Stud 39:156-163, 1994.
81. Lai CH, Hsueh S, Chao AS, et al: Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma. Br J Obstet Gynaecol 101:547-549, 1994.